Press Releases April 12, 2026 08:00 PM

National Healthcare Properties Announces Launch of Public Offering

National Healthcare Properties Launches Public Offering of Class A Common Stock to Reduce Debt and Fund Acquisitions

By Leila Farooq NHP
National Healthcare Properties Announces Launch of Public Offering
NHP

National Healthcare Properties, Inc. announced a public offering of 38.5 million shares of its Class A common stock, aiming to raise capital through an IPO priced between $13.00 and $16.00 per share. The net proceeds will be used to repay $186 million in revolving credit facility debt, finance potential future property acquisitions, and cover general corporate expenses. The shares are expected to be listed on Nasdaq under the ticker 'NHP'.

Key Points

  • NHP plans to offer 38.5 million shares of Class A common stock with an option for underwriters to purchase an additional 5.775 million shares.
  • Proceeds from the offering will primarily be used to reduce existing debt and fund future healthcare real estate acquisitions, focusing on senior housing and outpatient medical facilities.
  • The offering is managed by major financial institutions including Wells Fargo Securities, Morgan Stanley, and BMO Capital Markets, indicating substantial market support.

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (“NHP”) today announced the launch of its public offering of 38,500,000 shares of its Class A common stock pursuant to a registration statement on Form S-11 filed with the Securities and Exchange Commission (the “SEC”). The initial public offering price is expected to be between $13.00 and $16.00 per share. NHP expects to grant the underwriters a 30-day option to purchase up to an additional 5,775,000 shares of its Class A common stock to cover overallotments, if any. NHP has applied to list its Class A common stock on The Nasdaq Global Select Market under the symbol “NHP.”

NHP intends to use the net proceeds received from the offering to repay approximately $186.0 million of outstanding indebtedness under its revolving credit facility, to fund potential future property acquisitions and for other general corporate purposes.

Wells Fargo Securities, Morgan Stanley and BMO Capital Markets are acting as lead book-running managers for the offering. Goldman Sachs & Co. LLC, RBC Capital Markets, Baird, Capital One Securities, Citizens Capital Markets, Fifth Third Securities, Huntington Capital Markets and KeyBanc Capital Markets are acting as bookrunners for the offering. Credit Agricole CIB and Synovus are acting as co-managers for the offering.

The offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering may be obtained from: Wells Fargo Securities, LLC, 90 South 7th Street, 5th Floor, Minneapolis, Minnesota 55402, by telephone at (800) 645-3751 (option #5), or by email at [email protected]; Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; or BMO Capital Markets Corp., Attn: Equity Syndicate Department, 151 West 42nd Street, 32nd Floor, New York, New York 10036, or by email at [email protected].

A registration statement relating to the offering has been filed with the SEC but has not yet been declared effective. Securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement is declared effective by the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About National Healthcare Properties, Inc.

National Healthcare Properties, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on senior housing and outpatient medical facilities located in the United States.

Forward-Looking Statements

This press release contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things: NHP’s expectations regarding the pricing, completion and size of the offering; the anticipated terms of the offering; NHP’s use of proceeds from the offering; and the realization of any potential advantages, benefits and the impact of, and opportunities created by, the offering. When NHP uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. NHP’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited, the risks and uncertainties described in the section titled “Risk Factors” in the registration statement relating to the offering and all other filings with the SEC. Finally, NHP assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

Contacts

Investors and Media:
Email: [email protected]


Risks

  • The final offering price and size are subject to market conditions and SEC approval, which may affect capital raised and timing.
  • Use of proceeds includes future acquisitions which carry risks of integration, market conditions, and asset performance within the healthcare real estate sector.
  • General market volatility and uncertainties inherent in real estate investment trusts and healthcare real estate markets may impact stock performance and investment returns.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026